<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39424372</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-6641</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>BMJ open quality</Title><ISOAbbreviation>BMJ Open Qual</ISOAbbreviation></Journal><ArticleTitle>Exploring virtual delivery of academic detailing to general practitioners compared with in-person delivery: a qualitative study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e002444</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjoq-2023-002444</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Inappropriate prescribing may have detrimental consequences for the patient and increase healthcare utilisation and costs. Academic detailing (AD) is an interactive outreach method to deliver non-commercial evidence-based medical information to healthcare professionals, aiming to improve patient care. Performing AD virtually has recently become more relevant, especially with the COVID-19 pandemic.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to explore general practitioners' (GP's) experiences and perceptions of virtually delivered AD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We invited practicing GPs that had received virtual AD in Norway during autumn 2020. Semistructured individual interviews were audio and video recorded during February-May 2021. Interviews were transcribed and analysed applying thematic analysis according to Braun and Clarke.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From interviews with nine GPs, we identified five themes concerning (1) informants' satisfaction with virtual AD and their opinions about the detailers and their characteristics, (2) factors that are important for participation in AD, with the campaign topic being the most important, (3) a paradox between the informants' desire for more time for discussion and the time constraint they are facing, (4) the many benefits of virtual AD compared with in-person AD and (5) the informants' perceived learning outcomes are unaffected by mode of AD delivery.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Virtual AD worked very well in terms of scheduling the visit, using technology to facilitate the visit and achieving the same learning outcomes. Virtual AD should be offered to GPs as an alternative to the traditional in-person AD, especially in remote geographical areas or in circumstances when physical outreach is challenging.</AbstractText><CopyrightInformation>© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Beate Hennie</ForeName><Initials>BH</Initials><Identifier Source="ORCID">0000-0002-0815-0383</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy, UiT The Arctic University of Norway, Tromsø, Norway beate.garcia@uit.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Pharmacy of North Norway Trust, Tromsø, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langaas</LastName><ForeName>Harald Christian</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology, St. Olavs Hospital Trondheim University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regional Medicines Information and Pharmacovigilance Centre (RELIS Midt-Norge), St. Olavs Hospital Trondheim University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahnsen</LastName><ForeName>Jan Anker</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Regional Medicines Information and Pharmacovigilance Centre (RELIS Vest), Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schjøtt</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Regional Medicines Information and Pharmacovigilance Centre (RELIS Vest), Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nilsen</LastName><ForeName>Terje</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, UiT The Arctic University of Norway, Tromsø, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regional Medicines Information and Pharmacovigilance Centre (RELIS Nord-Norge), University Hospital of North Norway, Tromsø, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehnbom</LastName><ForeName>Elin Christina</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, UiT The Arctic University of Norway, Tromsø, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Qual</MedlineTA><NlmUniqueID>101710381</NlmUniqueID><ISSNLinking>2399-6641</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="Y">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N" Type="Geographic">Norway</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058005" MajorTopicYN="Y">General Practitioners</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001291" MajorTopicYN="N">Attitude of Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="N">Telemedicine</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Educational outreach, academic detialing</Keyword><Keyword MajorTopicYN="N">General practice</Keyword><Keyword MajorTopicYN="N">Qualitative research</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>21</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39424372</ArticleId><ArticleId IdType="pmc">PMC11492952</ArticleId><ArticleId IdType="doi">10.1136/bmjoq-2023-002444</ArticleId><ArticleId IdType="pii">bmjoq-2023-002444</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khatter A, Moriarty F, Ashworth M, et al. Prevalence and predictors of potentially inappropriate prescribing in middle-aged adults: a repeated cross-sectional study. Br J Gen Pract. 2021;71:e491–7. doi: 10.3399/BJGP.2020.1048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2020.1048</ArticleId><ArticleId IdType="pmc">PMC8136579</ArticleId><ArticleId IdType="pubmed">33606659</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Medications without harm. 2017.  [29-Jun-2022]. https://www.who.int/initiatives/medication-without-harm Available. Accessed.</Citation></Reference><Reference><Citation>Díaz Planelles I, Navarro-Tapia E, García-Algar Ó, et al. Prevalence of Potentially Inappropriate Prescriptions According to the New STOPP/START Criteria in Nursing Homes: A Systematic Review. Healthcare (Basel) 2023;11:422. doi: 10.3390/healthcare11030422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11030422</ArticleId><ArticleId IdType="pmc">PMC9914658</ArticleId><ArticleId IdType="pubmed">36766997</ArticleId></ArticleIdList></Reference><Reference><Citation>Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based “detailing.”. N Engl J Med. 1983;308:1457–63. doi: 10.1056/NEJM198306163082406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198306163082406</ArticleId><ArticleId IdType="pubmed">6406886</ArticleId></ArticleIdList></Reference><Reference><Citation>Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing’) to improve clinical decision making. JAMA. 1990;263:549–56.</Citation><ArticleIdList><ArticleId IdType="pubmed">2104640</ArticleId></ArticleIdList></Reference><Reference><Citation>Avorn J. Academic Detailing: “Marketing” the Best Evidence to Clinicians. JAMA. 2017;317:361–2. doi: 10.1001/jama.2016.16036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.16036</ArticleId><ArticleId IdType="pubmed">28118458</ArticleId></ArticleIdList></Reference><Reference><Citation>Langaas HC, Hurley E, Dyrkorn R, et al. Effectiveness of an academic detailing intervention in primary care on the prescribing of non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol. 2019;75:577–86. doi: 10.1007/s00228-018-02611-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-018-02611-y</ArticleId><ArticleId IdType="pubmed">30596208</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyrkorn R, Langaas HC, Giverhaug T, et al. Academic detailing as a method of continuing medical education. Adv Med Educ Pract. 2019;10:717–25. doi: 10.2147/AMEP.S206073.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/AMEP.S206073</ArticleId><ArticleId IdType="pmc">PMC6719842</ArticleId><ArticleId IdType="pubmed">31507335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruyndonckx R, Verhoeven V, Anthierens S, et al. The implementation of academic detailing and its effectiveness on appropriate prescribing of pain relief medication: a real-world cluster randomized trial in Belgian general practices. Implement Sci. 2018;13:6. doi: 10.1186/s13012-017-0703-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-017-0703-8</ArticleId><ArticleId IdType="pmc">PMC5761112</ArticleId><ArticleId IdType="pubmed">29316945</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar PR, Jha N, Piryani RM, et al. Academic detailing. Kathmandu Univ Med J (KUMJ) . 2010;8:126–34. doi: 10.3126/kumj.v8i1.3235.</Citation><ArticleIdList><ArticleId IdType="doi">10.3126/kumj.v8i1.3235</ArticleId><ArticleId IdType="pubmed">21209521</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemec PB. Academic detailing. Psychiatr Rehabil J. 2011;34:257–9. doi: 10.2975/34.3.2011.257.259.</Citation><ArticleIdList><ArticleId IdType="doi">10.2975/34.3.2011.257.259</ArticleId><ArticleId IdType="pubmed">21208867</ArticleId></ArticleIdList></Reference><Reference><Citation>RELIS (Regional Medicines and Pharmacovigilance Center)  About relis.  [29-Jun-2022]. https://www.relis.no/about_relis Available. Accessed.</Citation></Reference><Reference><Citation>Schjøtt J. Benefits of a national network of drug information centres: RELIS. Eur J Clin Pharmacol. 2017;73:125–6. doi: 10.1007/s00228-016-2129-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-016-2129-7</ArticleId><ArticleId IdType="pmc">PMC5203813</ArticleId><ArticleId IdType="pubmed">27637913</ArticleId></ArticleIdList></Reference><Reference><Citation>Langaas HC, Salvesen Ø, Dyrkorn R, et al. Academic detailing as a method to improve general practitioners’ drug prescribing in type 2 diabetes: evaluation of changes in prescribing. Scand J Prim Health Care. 2023;41:224–31. doi: 10.1080/02813432.2023.2222781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02813432.2023.2222781</ArticleId><ArticleId IdType="pmc">PMC10478614</ArticleId><ArticleId IdType="pubmed">37326464</ArticleId></ArticleIdList></Reference><Reference><Citation>Espnes KA, Nøst TH, Handal M, et al. Can academic detailing reduce opioid prescriptions in chronic non-cancer pain? BMC Prim Care. 2023;24:84. doi: 10.1186/s12875-023-02040-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12875-023-02040-6</ArticleId><ArticleId IdType="pmc">PMC10042395</ArticleId><ArticleId IdType="pubmed">36973685</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman JD, Shayegani R, Spoutz PM, et al. Virtual academic detailing (e-Detailing): A vital tool during the COVID-19 pandemic. J Am Pharm Assoc (2003) 2020;60:e95–9. doi: 10.1016/j.japh.2020.06.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.japh.2020.06.028</ArticleId><ArticleId IdType="pmc">PMC7833607</ArticleId><ArticleId IdType="pubmed">32747164</ArticleId></ArticleIdList></Reference><Reference><Citation>Himstreet JE, Shayegani R, Spoutz P, et al. Implementation of a pharmacy-led virtual academic detailing program at the US Veterans Health Administration. Am J Health Syst Pharm. 2022;79:909–17. doi: 10.1093/ajhp/zxac024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajhp/zxac024</ArticleId><ArticleId IdType="pubmed">35084487</ArticleId></ArticleIdList></Reference><Reference><Citation>Smart MH, Mandava MR, Lee TA, et al. Feasibility and acceptability of virtual academic detailing on opioid prescribing. Int J Med Inform. 2021;147:104365. doi: 10.1016/j.ijmedinf.2020.104365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2020.104365</ArticleId><ArticleId IdType="pmc">PMC8040528</ArticleId><ArticleId IdType="pubmed">33360790</ArticleId></ArticleIdList></Reference><Reference><Citation>Bounthavong M, Shayegani R, Manning JM, et al. Comparison of virtual to in-person academic detailing on naloxone prescribing rates at three U.S. Veterans Health Administration regional networks. Int J Med Inform. 2022;161:104712. doi: 10.1016/j.ijmedinf.2022.104712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2022.104712</ArticleId><ArticleId IdType="pubmed">35196600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung DM, Hamer A, Middleton L, et al. A pilot study evaluating alternative approaches of academic detailing in rural family practice clinics. BMC Fam Pract. 2012;13:129. doi: 10.1186/1471-2296-13-129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2296-13-129</ArticleId><ArticleId IdType="pmc">PMC3558441</ArticleId><ArticleId IdType="pubmed">23276303</ArticleId></ArticleIdList></Reference><Reference><Citation>Donabedian A. Evaluating the Quality of Medical Care. Milbank Mem Fund Q. 1966;44:166. doi: 10.2307/3348969.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/3348969</ArticleId><ArticleId IdType="pubmed">5338568</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi-Moghaddam MA, Zarei E, Bagherzadeh R, et al. Evaluation of service quality from patients’ viewpoint. BMC Health Serv Res. 2019;19:170. doi: 10.1186/s12913-019-3998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-019-3998-0</ArticleId><ArticleId IdType="pmc">PMC6420766</ArticleId><ArticleId IdType="pubmed">30876453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunnskapsbaserte oppdateringsvisitter (KUPP). Riktigere bruk av opioider ved langvarige ikke-maligne smerter (Eng. More appropriate use of opioids with long-term non-malignant pain) 2017. https://relis.no/wp-content/uploads/2023/03/KUPP-opioider-sidedelt-med-innstikk.pdf Available.</Citation></Reference><Reference><Citation>Malterud K, Siersma VD, Guassora AD. Sample Size in Qualitative Interview Studies: Guided by Information Power. Qual Health Res. 2016;26:1753–60. doi: 10.1177/1049732315617444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049732315617444</ArticleId><ArticleId IdType="pubmed">26613970</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101. doi: 10.1191/1478088706qp063oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1478088706qp063oa</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. What can “thematic analysis” offer health and wellbeing researchers? Int J Qual Stud Health Well-being . 2014;9:26152. doi: 10.3402/qhw.v9.26152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/qhw.v9.26152</ArticleId><ArticleId IdType="pmc">PMC4201665</ArticleId><ArticleId IdType="pubmed">25326092</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton MQ. Qualitative Evaluation and Research Methods, 2nd Ed. Sage Publications, Inc; 1990.</Citation></Reference><Reference><Citation>Graneheim UH, Lindgren BM, Lundman B. Methodological challenges in qualitative content analysis: A discussion paper. Nurse Educ Today. 2017;56:29–34. doi: 10.1016/j.nedt.2017.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nedt.2017.06.002</ArticleId><ArticleId IdType="pubmed">28651100</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349–57. doi: 10.1093/intqhc/mzm042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzm042</ArticleId><ArticleId IdType="pubmed">17872937</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hoof TJ, Harrison LG, Miller NE, et al. Characteristics of Academic Detailing: Results of a Literature Review. Am Health Drug Benefits. 2015;8:414–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684632</ArticleId><ArticleId IdType="pubmed">26702333</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlinghaus KR, Johnston CA. Advocating for Behavior Change With Education. Am J Lifestyle Med. 2018;12:113–6. doi: 10.1177/1559827617745479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1559827617745479</ArticleId><ArticleId IdType="pmc">PMC6124997</ArticleId><ArticleId IdType="pubmed">30283247</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFilippis E, Impink SM, Singell M, et al. The impact of COVID-19 on digital communication patterns. Humanit Soc Sci Commun . 2022;9:180. doi: 10.1057/s41599-022-01190-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1057/s41599-022-01190-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Nenninger A, Ball SJ, Kennedy AG, et al. “You’re on mute”—lessons learned with virtual academic detailing. J Am Pharm Assoc (2003) 2022;62:1154–7. doi: 10.1016/j.japh.2022.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.japh.2022.02.002</ArticleId><ArticleId IdType="pmc">PMC9550560</ArticleId><ArticleId IdType="pubmed">35246402</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowett D. Improving Use of Medicines and Medical Tests in Primary Care. Detailing: Springer; 2020. Chapter 4: evidence for and implementation of academic detailing.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>